Corbion reported third-quarter organic sales growth of 7.6%, adjusted EBITDA growth of 28.2%, and an adjusted EBITDA margin of 18.8%, up 290 basis points. Both segments had positive volume/mix, while the Health & Nutrition segment's margin improvement was linked to pricing; the shares fell about 5% that session.
Corbion's algae-derived omega-3 is used in salmon feed and competes with fish oil, but the reported results do not establish a change in feed-ingredient supply or prices. No clear near-term price implication for the listed feed commodities is indicated.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.